William Richard White is of Gemini Therapeutics, Inc. . Currently has a direct ownership of 0 shares of GMTX, which is worth approximately $0. The most recent transaction as insider was on Nov 04, 2024, when has been sold 7,136 shares (Common Stock) at a price of $58.26 per share, resulting in proceeds of $415,743. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

William Richard White Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 04 2024
SELL
Open market or private sale
$415,743 $58.26 p/Share
7,136 Reduced 100.0%
0 Common Stock
Nov 04 2024
BUY
Exercise of conversion of derivative security
$326,043 $45.69 p/Share
7,136 Added 50.0%
7,136 Common Stock
Nov 01 2024
SELL
Open market or private sale
$9,290 $46.22 p/Share
201 Reduced 100.0%
0 Common Stock
Nov 01 2024
BUY
Exercise of conversion of derivative security
$1,981 $9.86 p/Share
201 Added 50.0%
201 Common Stock
Oct 01 2024
SELL
Open market or private sale
$10,226 $50.88 p/Share
201 Reduced 100.0%
0 Common Stock
Oct 01 2024
BUY
Exercise of conversion of derivative security
$1,981 $9.86 p/Share
201 Added 50.0%
201 Common Stock
Sep 03 2024
SELL
Open market or private sale
$99,591 $50.89 p/Share
1,957 Reduced 100.0%
0 Common Stock
Sep 03 2024
BUY
Exercise of conversion of derivative security
$12,250 $6.26 p/Share
1,957 Added 50.0%
1,957 Common Stock
Aug 01 2024
SELL
Open market or private sale
$8,763 $43.6 p/Share
201 Reduced 100.0%
0 Common Stock
Aug 01 2024
BUY
Exercise of conversion of derivative security
$1,981 $9.86 p/Share
201 Added 50.0%
201 Common Stock
Jul 01 2024
SELL
Open market or private sale
$9,207 $45.81 p/Share
201 Reduced 100.0%
0 Common Stock
Jul 01 2024
BUY
Exercise of conversion of derivative security
$1,981 $9.86 p/Share
201 Added 50.0%
201 Common Stock
Jun 03 2024
SELL
Open market or private sale
$70,432 $35.99 p/Share
1,957 Reduced 100.0%
0 Common Stock
Jun 03 2024
BUY
Exercise of conversion of derivative security
$12,250 $6.26 p/Share
1,957 Added 50.0%
1,957 Common Stock
May 01 2024
SELL
Open market or private sale
$5,792 $28.82 p/Share
201 Reduced 100.0%
0 Common Stock
May 01 2024
BUY
Exercise of conversion of derivative security
$1,981 $9.86 p/Share
201 Added 50.0%
201 Common Stock
Apr 11 2024
SELL
Open market or private sale
$81,894 $31.99 p/Share
2,560 Reduced 100.0%
0 Common Stock
Apr 11 2024
BUY
Exercise of conversion of derivative security
$16,025 $6.26 p/Share
2,560 Added 50.0%
2,560 Common Stock
Dec 12 2023
SELL
Open market or private sale
$2,132,304 $63.63 p/Share
33,511 Reduced 100.0%
0 Common Stock
Dec 12 2023
BUY
Exercise of conversion of derivative security
$290,540 $8.67 p/Share
33,511 Added 50.0%
33,511 Common Stock

Also insider at

AKRO
Akero Therapeutics, Inc. Healthcare
VTYX
Ventyx Biosciences, Inc. Healthcare
WRW

William Richard White

South San Francisco, CA

Track Institutional and Insider Activities on GMTX

Follow Gemini Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Insider Trading

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if

News

Receive news related to Gemini Therapeutics, Inc.

Track Activities on GMTX